Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-12-20 to 2023-01-12
Current total value of award: $24838.08
Description: 4559437310!KRYSTEXXA 8 MG/ML VIALML